A South African haematologist has played a key role in a major international breakthrough for treating haemophilia A, a rare genetic disorder. The pioneering new gene therapy offers a potential “functional cure” and renewed hope for accessible treatment in low- and middle-income countries. This marks a significant milestone in haemophilia gene therapy. Professor Johnny Mahlangu, a leading haematologist at the…